AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. Its key products include Humira, Skyrizi, Rinvoq, and Botox, spanning immunology, oncology, aesthetics, neuroscience, and eye care therapeutic areas.
AbbVie Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ABBV.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ABBV Stock Intelligence Report. [stoxpulse.com/stocks/abbv]
Disclaimer: The information on this page about AbbVie Inc. (ABBV) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for AbbVie Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings miss
Jun 30
Donoghoe bought 33K shares
Aug 14
Donoghoe sold 33K shares
Aug 14
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruc...
6h ago
AbbVie vs. Pfizer: Which Healthcare Stock Is a Bet...
11h ago
StoxPulse AI results for ABBV: Pulse Score 52/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$453.19B
P/E Ratio
96.8
EPS
$1.02
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+2.7%
Dec 25
+0.2%
Mar 26
+0.2%
Jun 26
-0.7%
Beat estimates 3 of 4 quarters (75%)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. Its key products include Humira, Skyrizi, Rinvoq, and Botox, spanning immunology, oncology, aesthetics, neuroscience, and eye care therapeutic areas.
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Was JNJ Stock Rally Actually Its Own?
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
The Zacks Analyst Blog Highlights Amazon.com, AbbVie, Alibaba and Lulu's Fashion Lounge
Here Are 5 ETFs That Retirees Use to Skip Stock Picking Entirely